- Home
- FLUX vs KZR Comparison
FLUX vs KZR Comparison
Compare FLUX & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- KZR
- Stock Information
- Founded
- FLUX N/A
- KZR 2015
- Country
- FLUX United States
- KZR United States
- Employees
- FLUX N/A
- KZR N/A
- Industry
- FLUX Industrial Machinery/Components
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- KZR Health Care
- Exchange
- FLUX Nasdaq
- KZR Nasdaq
- Market Cap
- FLUX 25.4M
- KZR 29.7M
- IPO Year
- FLUX N/A
- KZR 2018
- Fundamental
- Price
- FLUX $1.84
- KZR $3.97
- Analyst Decision
- FLUX Strong Buy
- KZR Hold
- Analyst Count
- FLUX 2
- KZR 2
- Target Price
- FLUX $6.00
- KZR $9.00
- AVG Volume (30 Days)
- FLUX 80.8K
- KZR 42.0K
- Earning Date
- FLUX 08-26-2025
- KZR 08-13-2025
- Dividend Yield
- FLUX N/A
- KZR N/A
- EPS Growth
- FLUX N/A
- KZR N/A
- EPS
- FLUX N/A
- KZR N/A
- Revenue
- FLUX $63,074,000.00
- KZR N/A
- Revenue This Year
- FLUX $11.10
- KZR N/A
- Revenue Next Year
- FLUX $12.66
- KZR N/A
- P/E Ratio
- FLUX N/A
- KZR N/A
- Revenue Growth
- FLUX N/A
- KZR N/A
- 52 Week Low
- FLUX $1.15
- KZR $3.62
- 52 Week High
- FLUX $3.64
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- FLUX 54.74
- KZR 39.86
- Support Level
- FLUX $1.63
- KZR $3.98
- Resistance Level
- FLUX $1.79
- KZR $4.07
- Average True Range (ATR)
- FLUX 0.15
- KZR 0.15
- MACD
- FLUX 0.02
- KZR -0.02
- Stochastic Oscillator
- FLUX 71.19
- KZR 13.73
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.